Designed around the way
your specialty works.
Longitudinal lesion/body-map record with clinical images, disease severity and specimen linkage.
Capture distribution, morphology, symptoms, triggers, previous therapies and full skin examination with a body map.
Maintain persistent lesion identifiers for dermoscopy, serial photography, biopsy/excision and pathology correlation.
Provide acne, eczema, psoriasis, hair/nail and skin-cancer follow-up forms with disease-appropriate measures and treatment monitoring.
Track systemic/biologic therapy investigations, phototherapy exposures, adverse effects and lesion surveillance recalls.
Diagnosis coverage and clinical records
Atopic dermatitis, psoriasis, acne, rosacea, infectious dermatoses, alopecia, pigment disorders, urticaria, benign lesions, suspected melanoma and keratinocyte cancers. Preserve differential diagnosis until clinician/pathology confirmation; annotate morphology and site.
Measurements that give the record meaning
| Measurement | Units / representation | Clinical context |
|---|---|---|
| Lesion size | mm | Persistent lesion ID, location and method |
| Affected body surface | % | Method and disease context |
| Disease severity | PASI/EASI or chosen score | Version, components, assessor and licensing |
| Quality of life/itch | instrument score | Validated language and age applicability |
| Hair density | hairs/cm² | Site and imaging method |
| Phototherapy exposure | mJ/cm² or J/cm² | Modality, wavelength, session and cumulative exposure |
| Skin image metadata | scale and colour reference | Lighting, dermoscope and body-map location |
Equipment and integration plans
- Dermoscopes, total-body photography and slide/pathology systems → image/specimen links; AI lesion triage only as a separately validated aid.
- Phototherapy units and lasers → authorized session logs; raw device exposure units remain intact with interpretation.
Connections require an approved interface and testing against the installed manufacturer, model and software. Listed equipment is a candidate integration target.
Explore equipment & roboticsReporting and meaningful outcomes
Biopsy-to-reviewed-result interval; surveillance recall completion; severity change using comparable instruments; therapy-monitoring completion.
Development scope and clinical validation
Initial scope
Body maps, photographs, disease templates, biopsy tracking and medication monitoring.
Advanced scope
Dermoscopy integration, total-body image matching and phototherapy device records.
Example acceptance scenarios
- A lesion biopsy cannot be closed until its pathology result is matched and reviewed.
- Scores must show components and instrument version; an incomplete score cannot silently become zero disease activity.
Research foundations
Research snapshot: 23 September 2026. References inform the proposed design; they do not certify FertPro or establish device compatibility. Diagnosis lists and measurement groups are not treatment protocols.